Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
TFF Pharmaceuticals, Inc. (TFFP)
|
Add to portfolio |
|
|
|
| Price: |
$8.68
| | Metrics |
| OS: |
36.3
|
M
| |
|
|
| Market cap: |
$315
|
M
| |
|
|
|
Net cash:
|
$7.66
|
M
| |
$0.21
|
per share
|
|
EV:
|
$307
|
M
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
($26.4)
|
M
| |
|
|
|
EBIT
|
($26.9)
|
M
| |
|
|
| EPS |
$0.53
| |
16.4
|
x P/E
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-17 |
| Revenues | 0.5 | 0.1 | 0.0 | 13.0 | 0.0 |
| Revenue growth | 462.4% | | -100.0% | | |
| Cost of goods sold | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Gross profit | 0.5 | 0.1 | 0.0 | 13.0 | 0.0 |
| Gross margin | 100.0% | 100.0% | | 100.0% | |
| Research and development | 18.5 | 21.3 | 10.7 | 8.8 | |
| General and administrative | 13.8 | 10.6 | 8.0 | 3.2 | 178.6 |
| EBIT | -31.8 | -31.8 | -18.7 | -11.0 | -178.6 |
| EBIT margin | -6413.2% | -36055.2% | | -84.9% | |
| Pre-tax income | -31.8 | -31.0 | -18.6 | -11.9 | -178.6 |
| Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | 0.0 | 0.0 | 0.0 | -36.7 | -178.6 |
| Net margin | 0.0% | 0.0% | | -282.9% | |
| |
| Diluted EPS | $0.00 | $0.00 | $0.00 | ($5.31) | |
| Shares outstanding (diluted) | 30.0 | 24.8 | 20.4 | 6.9 | |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|